These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 10448519)

  • 21. Hyaluronan forms complexes with low density lipoprotein while also inducing foam cell infiltration in the dermis.
    Seike M; Ikeda M; Matsumoto M; Hamada R; Takeya M; Kodama H
    J Dermatol Sci; 2006 Mar; 41(3):197-204. PubMed ID: 16356687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications.
    Tabas I; Williams KJ; Borén J
    Circulation; 2007 Oct; 116(16):1832-44. PubMed ID: 17938300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A modern view of atherogenesis.
    Schwartz CJ; Valente AJ; Sprague EA
    Am J Cardiol; 1993 Feb; 71(6):9B-14B. PubMed ID: 8434561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of oxidized lipoproteins in the pathogenesis of atherosclerosis.
    Kita T; Yokode M; Ishii K; Kume N; Nagano Y; Arai H; Otani H; Ueda Y; Hara S
    Clin Exp Pharmacol Physiol Suppl; 1992; 20():37-42. PubMed ID: 1446408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of oxidized low density lipoprotein with macrophages in atherosclerosis, and the antiatherogenicity of antioxidants.
    Aviram M
    Eur J Clin Chem Clin Biochem; 1996 Aug; 34(8):599-608. PubMed ID: 8877334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Triglyceride-rich lipoproteins and atherosclerosis: pathophysiological considerations.
    Bradley WA; Gianturco SH
    J Intern Med Suppl; 1994; 736():33-9. PubMed ID: 7986306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipid transport aspects of atherogenesis.
    Weinbaum S; Chien S
    J Biomech Eng; 1993 Nov; 115(4B):602-10. PubMed ID: 8302048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of microscopy in understanding atherosclerotic lysosomal lipid metabolism.
    Jerome WG; Yancey PG
    Microsc Microanal; 2003 Feb; 9(1):54-67. PubMed ID: 12597787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retention of atherogenic lipoproteins in the artery wall and its role in atherogenesis.
    Fogelstrand P; Borén J
    Nutr Metab Cardiovasc Dis; 2012 Jan; 22(1):1-7. PubMed ID: 22176921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipoprotein modification and macrophage uptake: role of pathologic cholesterol transport in atherogenesis.
    Miller YI; Choi SH; Fang L; Tsimikas S
    Subcell Biochem; 2010; 51():229-51. PubMed ID: 20213546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Why are plasmatic apoB lipoproteins atherogenic? The hypothesis of response to retention].
    Hurt-Camejo E; Camejo G
    Invest Clin; 2001 May; 42 Suppl 1():43-73. PubMed ID: 11416984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Macrophages, endothelial cells, and lipoprotein oxidation in the pathogenesis of atherosclerosis.
    Rosenfeld ME; Palinski W; Ylä-Herttuala S; Carew TE
    Toxicol Pathol; 1990; 18(4 Pt 1):560-71. PubMed ID: 2091235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Important role for bone marrow-derived cholesteryl ester transfer protein in lipoprotein cholesterol redistribution and atherosclerotic lesion development in LDL receptor knockout mice.
    Van Eck M; Ye D; Hildebrand RB; Kar Kruijt J; de Haan W; Hoekstra M; Rensen PC; Ehnholm C; Jauhiainen M; Van Berkel TJ
    Circ Res; 2007 Mar; 100(5):678-85. PubMed ID: 17293475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low density lipoprotein stimulation of human macrophage proteoglycan secretion.
    Lindholm MW; Nilsson J; Moses J
    Biochem Biophys Res Commun; 2005 Mar; 328(2):455-60. PubMed ID: 15694369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atherosclerosis--reversal with therapy.
    Blankenhorn DH; Hodis HN
    West J Med; 1993 Aug; 159(2):172-9. PubMed ID: 8212682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Serum lipoprotein and atherogenicity--relationship with particle size and composition of low density lipoproteins, and their modifications by oxidation and glycation].
    Takeuchi N; Saheki S
    Rinsho Byori; 1995 Aug; 43(8):753-62. PubMed ID: 7474432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Metabolism and possible mechanisms of atherogenesis induced by lipoprotein (a)].
    Krempler F
    Wien Klin Wochenschr Suppl; 1984; 151():1-12. PubMed ID: 6091345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Triglyceride-rich lipoproteins as risk factors for atherosclerosis].
    Schwandt P
    Klin Wochenschr; 1990; 68 Suppl 22():54-8. PubMed ID: 2087080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism of lipoprotein retention by the extracellular matrix.
    Gustafsson M; Borén J
    Curr Opin Lipidol; 2004 Oct; 15(5):505-14. PubMed ID: 15361785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modified lipoproteins, cytokines and macrovascular disease in non-insulin-dependent diabetes mellitus.
    Lopes-Virella MF; Virella G
    Ann Med; 1996 Aug; 28(4):347-54. PubMed ID: 8862690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.